ImportRefusal LogoImportRefusal

Sabdaalaya Audio

⚠️ Moderate Risk

FEI: 3004511973 • Hyderabad, Telangana • INDIA

FEI

FEI Number

3004511973

📍

Location

Hyderabad, Telangana

🇮🇳

Country

INDIA
🏢

Address

Plot No, 5 L V Prasad Road, Hyderabad, Telangana, India

Moderate Risk

FDA Import Risk Assessment

45.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
2
Unique Violations
6/28/2004
Latest Refusal
6/28/2004
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
70.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1187×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
6/28/2004
62CCA65LISINOPRIL (ANTI-HYPERTENSIVE)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
6/28/2004
62CCA10CLONIDINE HCL (ANTI-HYPERTENSIVE)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
6/28/2004
61JCA11GEMFIBROZIL (ANTI-CHOLESTEREMIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
6/28/2004
60XCA02METOPROLOL (ANTI-ADRENERGIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
6/28/2004
62OCA14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
6/28/2004
64BCA24FUROSEMIDE (DIURETIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
6/28/2004
62BDA99ANTI-HYPERLIPIDEMIC N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is Sabdaalaya Audio's FDA import refusal history?

Sabdaalaya Audio (FEI: 3004511973) has 7 FDA import refusal record(s) in our database, spanning from 6/28/2004 to 6/28/2004.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Sabdaalaya Audio's FEI number is 3004511973.

What types of violations has Sabdaalaya Audio received?

Sabdaalaya Audio has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Sabdaalaya Audio come from?

All FDA import refusal data for Sabdaalaya Audio is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.